News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
722,283 Results
Type
Article (40937)
Company Profile (267)
Press Release (681068)
Multimedia
Podcasts (81)
Webinars (17)
Section
Business (204675)
Career Advice (2025)
Deals (35534)
Drug Delivery (111)
Drug Development (81386)
Employer Resources (173)
FDA (16419)
Job Trends (14947)
News (346413)
Policy (32732)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2571)
Accelerated approval (34)
Adcomms (24)
Allergies (145)
Alliances (49575)
ALS (170)
Alzheimer's disease (1676)
Antibody-drug conjugate (ADC) (314)
Approvals (16690)
Artificial intelligence (520)
Autoimmune disease (160)
Automation (42)
Bankruptcy (361)
Best Places to Work (11636)
BIOSECURE Act (20)
Biosimilars (193)
Biotechnology (174)
Bladder cancer (160)
Brain cancer (57)
Breast cancer (645)
Cancer (4859)
Cardiovascular disease (406)
Career advice (1710)
Career pathing (36)
CAR-T (283)
CDC (46)
Celiac Disease (2)
Cell therapy (749)
Cervical cancer (36)
Clinical research (69621)
Collaboration (1717)
Company closure (4)
Compensation (1179)
Complete response letters (57)
COVID-19 (2714)
CRISPR (93)
C-suite (863)
Cystic fibrosis (143)
Data (6304)
Decentralized trials (2)
Denatured (25)
Depression (135)
Diabetes (504)
Diagnostics (6711)
Digital health (49)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (255)
Drug pricing (184)
Drug shortages (28)
Duchenne muscular dystrophy (234)
Earnings (90263)
Editorial (58)
Employer branding (21)
Employer resources (152)
Events (117421)
Executive appointments (981)
FDA (19571)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (11)
Frontotemporal dementia (23)
Funding (1481)
Gene editing (199)
Generative AI (44)
Gene therapy (597)
GLP-1 (967)
Government (4667)
Grass and pollen (6)
Guidances (384)
Healthcare (18881)
HIV (62)
Huntington's disease (45)
IgA nephropathy (84)
Immunology and inflammation (254)
Immuno-oncology (60)
Indications (119)
Infectious disease (2991)
Inflammatory bowel disease (195)
Inflation Reduction Act (14)
Influenza (119)
Intellectual property (254)
Interviews (316)
IPO (16643)
IRA (50)
Job creations (3643)
Job search strategy (1428)
JPM (57)
Kidney cancer (16)
Labor market (86)
Layoffs (547)
Leadership (32)
Legal (7951)
Liver cancer (91)
Longevity (15)
Lung cancer (658)
Lymphoma (382)
Machine learning (42)
Management (59)
Manufacturing (808)
MASH (164)
Medical device (13778)
Medtech (13835)
Mergers & acquisitions (19967)
Metabolic disorders (1274)
Multiple sclerosis (164)
NASH (16)
Neurodegenerative disease (321)
Neuropsychiatric disorders (89)
Neuroscience (2924)
Neurotech (1)
NextGen: Class of 2026 (6519)
Non-profit (4515)
Now hiring (68)
Obesity (598)
Opinion (263)
Ovarian cancer (167)
Pain (200)
Pancreatic cancer (230)
Parkinson's disease (284)
Partnered (33)
Patents (507)
Patient recruitment (497)
Peanut (57)
People (58917)
Pharmaceutical (62)
Pharmacy benefit managers (29)
Phase 1 (21704)
Phase 2 (30639)
Phase 3 (22828)
Pipeline (5452)
Policy (287)
Postmarket research (2564)
Preclinical (9202)
Press Release (64)
Prostate cancer (240)
Psychedelics (48)
Radiopharmaceuticals (283)
Rare diseases (846)
Real estate (5955)
Recruiting (70)
Regulatory (24555)
Reports (53)
Research institute (2391)
Resumes & cover letters (352)
Rett syndrome (27)
RNA editing (16)
RSV (81)
Schizophrenia (150)
Series A (240)
Series B (191)
Service/supplier (11)
Sickle cell disease (97)
Special edition (22)
Spinal muscular atrophy (157)
Sponsored (42)
Startups (3615)
State (2)
Stomach cancer (18)
Supply chain (105)
Tariffs (84)
The Weekly (54)
Vaccines (1013)
Venture capital (89)
Weight loss (381)
Women's health (93)
Worklife (18)
Date
Today (30)
Last 7 days (575)
Last 30 days (2235)
Last 365 days (29757)
2026 (4013)
2025 (30172)
2024 (35215)
2023 (40075)
2022 (51174)
2021 (55710)
2020 (54083)
2019 (46538)
2018 (35018)
2017 (32108)
2016 (31480)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (736)
Alabama (85)
Alaska (7)
Arizona (311)
Arkansas (13)
Asia (39239)
Australia (6416)
California (11400)
Canada (3320)
China (1104)
Colorado (480)
Connecticut (483)
Delaware (341)
Europe (84613)
Florida (1710)
Georgia (361)
Hawaii (3)
Idaho (61)
Illinois (872)
India (70)
Indiana (527)
Iowa (22)
Japan (436)
Kansas (127)
Kentucky (40)
Louisiana (26)
Maine (72)
Maryland (1394)
Massachusetts (8158)
Michigan (327)
Minnesota (631)
Mississippi (5)
Missouri (128)
Montana (32)
Nebraska (28)
Nevada (122)
New Hampshire (79)
New Jersey (3028)
New Mexico (28)
New York (3004)
North Carolina (1466)
North Dakota (8)
Northern California (5580)
Ohio (338)
Oklahoma (21)
Oregon (41)
Pennsylvania (2306)
Puerto Rico (24)
Rhode Island (48)
South America (1108)
South Carolina (67)
South Dakota (1)
Southern California (4440)
Tennessee (177)
Texas (1755)
United States (40412)
Utah (340)
Vermont (1)
Virginia (264)
Washington D.C. (81)
Washington State (928)
West Virginia (4)
Wisconsin (111)
Wyoming (2)
722,283 Results for "neurocentria inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Neurocentria Announces Dr. Thomas Südhof to Join the Scientific Advisory Board
Neurocentria, Inc. has today announced that Dr. Thomas Südhof, Avram Goldstein Professor in Stanford University School of Medicine and an investigator of the Howard Hughes Medical Institute, has joined the company’s Scientific Advisory Board (SAB).
January 13, 2023
·
6 min read
Biotech Bay
New Research Study Reveals Critical Role of Magnesium in Regulating Brain Synapses and Cognition
Neurocentria Inc., a privately held late-stage biotechnology company developing novel therapies for Alzheimer’s disease, Attention Deficit Hyperactivity Disorder, Major Depressive Disorder and other neurodegenerative and neuropsychiatric disorders, has published a novel research paper identifying magnesium’s key role in synaptic and cognition regulation.
May 30, 2024
·
4 min read
Press Releases
BioSyent to Acquire Oral Science Inc.
February 9, 2026
·
10 min read
Press Releases
Coherus Oncology, Inc. Announces Closing of Public Offering of Common Stock
February 18, 2026
·
5 min read
Press Releases
Axogen, Inc. to Participate in Multiple Upcoming March 2026 Investor Conferences
February 17, 2026
·
1 min read
FDA
Neurocentria Obtains FDA Approval to Conduct Pivotal Phase IIb/III Clinical Trial for Testing Safety and Efficacy of Drug Candidate NRCT-101SR in Adults With ADHD
Neurocentria Inc., has received FDA approval to conduct a pivotal phase IIb/III human clinical trial to test the efficacy and safety of its leading drug candidate NRCT-101SR compared to inactive placebo in adults with ADHD.
February 15, 2022
·
5 min read
Press Releases
Inmar Intelligence awarded renewed Pharmacy Reverse Distribution agreement with Premier, Inc.
February 19, 2026
·
2 min read
Press Releases
Convatec awarded Enterostomal Therapy Products agreements with Premier, Inc.
February 10, 2026
·
2 min read
Press Releases
BrightSpring Health Services, Inc. to Host Investor Day on March 17, 2026
February 18, 2026
·
1 min read
Press Releases
Liminatus Pharma, Inc. Announces Pricing of $4.0 Million Public Offering
February 17, 2026
·
4 min read
1 of 72,229
Next
